...use of human and animal cells and was rejected by the U.S. Patent office because it "embraces human beings." Jeremy Rifkin, co-applicant for the patent and a well-known biotechnology activist, said the PTO failed to define how many...

...skeptics suggest it could end in bust. "This is the early stages of a profound revolution taking place," said Jeremy Rifkin, author of "The Hydrogen Economy." But even the Coleman engineer who developed the company's $6,000 AirGen...

...Reid said. The professor said that research suggests that crime increase in times of "structural unemployment." Jeremy Rifkin, who has written several books on the impact of technological advances on society, argues that crime is deeply rooted...

...of perfection? Meanwhile, we will continue to lean toward the alternation of human characteristics. According to Jeremy Rifkin, of the Foundation of Economic Trends, cloning would permit us to apply engineering to procreation. Children would...

...food is here to stay. "We didn't expect that they would move as fast as they did," said anti-biotech author Jeremy Rifkin, one of the first prominent Monsanto critics. Rifkin and others, including many European consumers, loathe genetically...

...complaint, filed in May, will only unify and mobilize Europeans in opposition. "It's going to backfire," said Jeremy Rifkin, a prominent anti-biotechnology author. "The United States made a tragic error in going to the WTO to push for...

...research effort, following the U.S. lead, might give short shift to research into renewable energy sources, says Jeremy Rifkin, an adviser to EU leaders on the hydrogren issues. He has characterized the administration's hydrogen initiative...

...research effort, following the U.S. lead, might give short shift to research into renewable energy sources, says Jeremy Rifkin, an adviser to EU leaders on the hydrogren issues. He has characterized the administration's hydrogen initiative...

...negotiate what is being called the Biosafety Protocol. "We're experiencing a big shift into a biotech century," said Jeremy Rifkin, who is president of the Washington-based Foundation on Economic Trends and wants a moratorium on the commercial...